Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-3-10
pubmed:abstractText
Emerging evidence indicates that in addition to their well-characterized role in antigen presentation, MHC II molecules transmit signals that induce death of APCs. Appropriately timed APC death is important for prevention of autoimmunity. Though the exact mechanism of MHC II-mediated cell death signaling is unknown, the response appears independent of caspase activation and does not involve Fas-FasL interaction. Here we investigated MHC II structural requirements for mediation of cell death signaling in a murine B cell lymphoma. We found that neither the transmembrane spanning regions nor the cytoplasmic tails of MHC II, which are required for MHC II-mediated cAMP production and PKC activation, are required for the death response. However, mutations in the connecting peptide region of MHC II alpha chain (alphaCP), but not the beta chain (betaCP), resulted in significant impairment of the death response. The alphaCP mutant was also unable to mediate calcium mobilization responses, and did not associate with Igalpha/beta. Knock-down of Igbeta by shRNA eliminated the MHC II-mediated calcium response but not cell death. We propose that MHC II mediates cell death signaling via association with an undefined cell surface protein(s), whose interaction is partially dependent on alphaCP region.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-10510346, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-10556806, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-11009095, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-11067914, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-11222857, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-11779298, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-11781242, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-11970986, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-12101408, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-12152028, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-12209641, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-12672059, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-14551703, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-14630799, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-14734118, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-14982950, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-15219998, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-15240889, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-1537587, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-15647325, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-15650447, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-16452241, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-16497935, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-16778139, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-2788709, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-7721346, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-8086377, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-8274197, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-8294884, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-8964075, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-9058721, http://linkedlifedata.com/resource/pubmed/commentcorrection/18194817-9933087
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0165-2478
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
184-94
pubmed:dateRevised
2010-12-3
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death.
pubmed:affiliation
Department of Immunology, University of Colorado at Denver and Health Sciences Center and National Jewish Medical and Research Center, Denver, CO 80206, United States.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural